| |
|
|
|
Aptevo Therapeutics Inc.  
|
|
5.54 -0.11 (-0.02%) |
06-22 16:00 |
|
Open: |
5.6 |
Pre close: |
5.65 |
Target:
|
7.11 
|
|
High: |
5.97 |
Low: |
5.49 |
Resistance:
|
6.09
7.11
|
|
Volume: |
338,650 |
Market Cap: |
125M |
Support:
|
4.96
4.26
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.24
 |
MACD |
MACD(12,26):
|
0.08 |
|
MA(20): |
5.25 |
Signal(12,26,9): |
0.08 |
|
MA(100): |
4.07 |
Stochastic Oscillator |
%K(14,3):
|
72.90 |
|
MA(250): |
3.21 |
%D(3): |
61.13 |
|
Average Volume(K) |
3-Month: |
19124
|
52-Week |
High:
|
6.35 |
|
10-Days: |
21037 |
Low: |
1.15 |
|
RSI |
RSI(14):
|
60.01 |
Change(%): |
148.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.020 |
Return on Equity (ttm) |
4.4 |
Shares Out. (M) |
22.59 |
|
EPS Est. Current Year |
0.590 |
Return on Assets (ttm) |
2.9 |
Shares Float (M) |
21.09 |
|
EPS Est. Next Year |
-2.690 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
2.250 |
Qtrly Rev. Growth |
90.1 |
% Held by Institutions |
31.00 |
|
Forward EPS |
-1.321 |
Gross Profit (p.s.) |
0.406 |
Shares Short (K) |
186 |
|
Book Value (p.s.) |
1.670 |
EBITDA (p.s.) |
-0.842 |
P/E |
-5.43 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.32 |
|
Profit Margin |
13.82 |
Operating Cash Flow
(M) |
-46.52 |
P/S |
162530640.00 |
|
Operating Margin |
-333.51 |
Levered Free Cash Flow
(M) |
-31.59 |
P/CF |
-2.69 |
|
|
|
|
|
|
